Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
The target population typically has better health than participants in health research studies, such as cancer screening trials (the "healthy volunteer" effect).
Read Full NewsHome visits — once common and now resurging — flip the dynamic, as the clinician becomes a guest in the patient's home. Experts say as both learn more about each other than is possible in-office, trust can build.
Higher body fat percentage, rather than BMI, is associated with reduced sperm count and disrupted reproductive hormone levels in men.
Standard TKI doses are often too high for long-term care. Dr Mark Kris shares his strategy for smart dose reductions that protect patient outcomes.
Cure rates are climbing, and so is the complexity of getting there. Dr Yara Abdou takes a closer look at optimizing HER2+ early-stage breast cancer therapy.
Direct primary care is more than medicine. Dr Rajdeep Dhami shares what physicians should know before starting DPC, from operations and branding to boundaries and community.
1.
US Counties Suffered Significantly from a Lack of Psychiatric Care.
2.
Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue
3.
Waiting for a Sharp Increase in Prostate Cancer Cases.
4.
Transperineal Biopsy IDs Active Surveillance Candidates
5.
EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer
1.
Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential
2.
Integrated Frameworks in Hematology in Clinical Decision-Making
3.
Community-Based Cancer Survivorship Support Systems
4.
How Prevident is Revolutionizing Oral Care
5.
Florinef: Understanding Its Uses and Side Effects
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
2.
Efficient Management of First line ALK-rearranged NSCLC - Part II
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
5.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge